October 18, 2007 - Hologic will demonstrate at RSNA 2007, its MammoSite, a targeted radiation therapy that works from the inside, meaning that a higher daily dose can be used for a shorter period of time, five days versus five to seven weeks.
MammoSite places the radiation source inside the lumpectomy cavity, delivering radiation to the area where cancer is most likely to recur. The therapy is given on an outpatient basis, no hospital stay is required.
The company will also highlight new features of the Selenia S digital mammography system, a product specifically designed for the screening mammography facility or mobile environment. Selenia S uses the Hologic direct conversion detector, eliminating the need to convert X-rays to light producing a sharp digital image reportedly with better contrast and detail.
For more information: www.hologic.com
March 06, 2026 
